Dilana E. Staudt

501 total citations
8 papers, 200 citations indexed

About

Dilana E. Staudt is a scholar working on Pharmacology, Genetics and Molecular Biology. According to data from OpenAlex, Dilana E. Staudt has authored 8 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Genetics and 2 papers in Molecular Biology. Recurrent topics in Dilana E. Staudt's work include Estrogen and related hormone effects (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Hormonal and reproductive studies (1 paper). Dilana E. Staudt is often cited by papers focused on Estrogen and related hormone effects (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Hormonal and reproductive studies (1 paper). Dilana E. Staudt collaborates with scholars based in Australia, Brazil and Belgium. Dilana E. Staudt's co-authors include Matthew D. Dun, Rafael Linden, Gilberto Schwartsmann, Nicole M. Verrills, Anoop Enjeti, Marina Venzon Antunes, Frank Alvaro, Jorge Villanova Biazús, José Antônio Crespo Cavalheiro and Heather C. Murray and has published in prestigious journals such as International Journal of Molecular Sciences, Talanta and Molecular Cancer Research.

In The Last Decade

Dilana E. Staudt

8 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dilana E. Staudt Australia	7	63	53	47	46	44	8	200
Richard D. Caldwell United States	8	118 1.9×	21 0.4×	172 3.7×	33 0.7×	47 1.1×	12	325
Ashley Eheim Germany	9	312 5.0×	16 0.3×	48 1.0×	30 0.7×	17 0.4×	11	429
Debra G. Goodwin United States	5	92 1.5×	15 0.3×	27 0.6×	108 2.3×	19 0.4×	7	257
Savita Lochab India	11	242 3.8×	10 0.2×	58 1.2×	16 0.3×	54 1.2×	26	362
Donald Souza United States	8	81 1.3×	19 0.4×	68 1.4×	60 1.3×	65 1.5×	11	263
Yushu Hao China	9	233 3.7×	24 0.5×	55 1.2×	42 0.9×	15 0.3×	22	445
Hua Yan China	9	165 2.6×	13 0.2×	46 1.0×	21 0.5×	7 0.2×	22	251
A. Keith Stewart United States	4	125 2.0×	55 1.0×	26 0.6×	17 0.4×	35 0.8×	14	213
I. Böttcher Switzerland	10	119 1.9×	44 0.8×	20 0.4×	118 2.6×	23 0.5×	24	373
Álvaro Lorente‐Macías Spain	6	165 2.6×	10 0.2×	60 1.3×	20 0.4×	7 0.2×	15	345

Countries citing papers authored by Dilana E. Staudt

Since Specialization

Citations

This map shows the geographic impact of Dilana E. Staudt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dilana E. Staudt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dilana E. Staudt more than expected).

Fields of papers citing papers by Dilana E. Staudt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dilana E. Staudt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dilana E. Staudt. The network helps show where Dilana E. Staudt may publish in the future.

Co-authorship network of co-authors of Dilana E. Staudt

This figure shows the co-authorship network connecting the top 25 collaborators of Dilana E. Staudt. A scholar is included among the top collaborators of Dilana E. Staudt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dilana E. Staudt. Dilana E. Staudt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

Staudt, Dilana E., et al.. (2023). CAR T cell therapies for diffuse midline glioma. Trends in cancer. 9(10). 791–804. 18 indexed citations

Jackson, Evangeline R., Dilana E. Staudt, Alicia M. Douglas, et al.. (2022). B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers. Molecular Cancer Research. 20(12). 1711–1723. 26 indexed citations

Staudt, Dilana E., Heather C. Murray, David A. Skerrett‐Byrne, et al.. (2022). Phospho-heavy-labeled-spiketide FAIMS stepped-CV DDA (pHASED) provides real-time phosphoproteomics data to aid in cancer drug selection. Clinical Proteomics. 19(1). 48–48. 2 indexed citations

Staudt, Dilana E., Heather C. Murray, Frank Alvaro, et al.. (2018). Targeting Oncogenic Signaling in Mutant FLT3 Acute Myeloid Leukemia: The Path to Least Resistance. International Journal of Molecular Sciences. 19(10). 3198–3198. 53 indexed citations

Antunes, Marina Venzon, Dilana E. Staudt, Jorge Villanova Biazús, et al.. (2015). Influence of CYP2D6 and CYP3A4 Phenotypes, Drug Interactions, and Vitamin D Status on Tamoxifen Biotransformation. Therapeutic Drug Monitoring. 37(6). 733–744. 21 indexed citations

Antunes, Marina Venzon, Dilana E. Staudt, Jorge Villanova Biazús, et al.. (2015). CYP3A4*22 is Related to Increased Plasma Levels of 4-Hydroxytamoxifen and Partially Compensates for Reduced CYP2D6 Activation of Tamoxifen. Pharmacogenomics. 16(6). 601–617. 24 indexed citations

Antunes, Marina Venzon, Dilana E. Staudt, Jorge Villanova Biazús, et al.. (2014). Development, validation and clinical application of a HPLC-FL method for CYP2D6 phenotyping in South Brazilian breast cancer patients. Clinical Biochemistry. 47(12). 1084–1090. 7 indexed citations

Antunes, Marina Venzon, Dilana E. Staudt, Jorge Villanova Biazús, et al.. (2014). Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N -desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots—Development, validation and clinical application during breast cancer adjuvant therapy. Talanta. 132. 775–784. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact